These results confirmed that ITGA10 overexpression enhanced the osteogenic differentiation potential of BMSCs from T2DM patients through the FAK/PI3K/AKT/GSK3β/β-catenin signaling pathway (Figure 6e). The gene discussed is GSK3B; the disease is type 2 diabetes mellitus.